Published in Respiratory Therapeutics Week, October 3rd, 2005
Study 1: The structure of the SARS coronavirus (SARS-CoV) frameshift signal has been elucidated, and a possible therapeutic target has been identified.
In a study conducted by E.P. Plant and colleagues at the University of Maryland, "inspection of the overlap regions between ORF1a and ORF1b of the SARS-CoV genome revealed that, similar to all coronaviruses, a programmed -1...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.